These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21524870)

  • 1. Magnetic resonance in the era of molecular imaging of cancer.
    Gore JC; Manning HC; Quarles CC; Waddell KW; Yankeelov TE
    Magn Reson Imaging; 2011 Jun; 29(5):587-600. PubMed ID: 21524870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Imaging of Tumor Metabolism with ¹H Magnetic Resonance Spectroscopy.
    Martín Noguerol T; Sánchez-González J; Martínez Barbero JP; García-Figueiras R; Baleato-González S; Luna A
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):57-86. PubMed ID: 26613876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous PET-MRI in oncology: a solution looking for a problem?
    Yankeelov TE; Peterson TE; Abramson RG; Izquierdo-Garcia D; Arlinghaus LR; Li X; Atuegwu NC; Catana C; Manning HC; Fayad ZA; Gore JC
    Magn Reson Imaging; 2012 Nov; 30(9):1342-56. PubMed ID: 22795930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular magnetic resonance contrast agents for the detection of cancer: past and present.
    Bogdanov A; Mazzanti ML
    Semin Oncol; 2011 Feb; 38(1):42-54. PubMed ID: 21362515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy Monitoring with Functional and Molecular MR Imaging.
    García-Figueiras R; Padhani AR; Baleato-González S
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):261-288. PubMed ID: 26613885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.
    Qiao J; Xue S; Pu F; White N; Jiang J; Liu ZR; Yang JJ
    J Biol Inorg Chem; 2014 Feb; 19(2):259-70. PubMed ID: 24366655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular breast imaging. An update].
    Pinker K; Helbich TH; Magometschnigg H; Fueger B; Baltzer P
    Radiologe; 2014 Mar; 54(3):241-53. PubMed ID: 24557495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast tumor imaging.
    Coll D
    Cancer Treat Res; 2008; 143():515-46. PubMed ID: 18619231
    [No Abstract]   [Full Text] [Related]  

  • 9. MR Imaging Biomarkers in Oncology Clinical Trials.
    Abramson RG; Arlinghaus LR; Dula AN; Quarles CC; Stokes AM; Weis JA; Whisenant JG; Chekmenev EY; Zhukov I; Williams JM; Yankeelov TE
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):11-29. PubMed ID: 26613873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging biomarkers in oncology: Basics and application to MRI.
    Dregely I; Prezzi D; Kelly-Morland C; Roccia E; Neji R; Goh V
    J Magn Reson Imaging; 2018 Jul; 48(1):13-26. PubMed ID: 29969192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
    Lu ZR; Laney V; Li Y
    Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
    Benz MR; Vargas HA; Sala E
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MR Imaging in Oncology.
    Mukherji SK
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):xv. PubMed ID: 26613886
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive molecular imaging using reporter genes.
    Brader P; Serganova I; Blasberg RG
    J Nucl Med; 2013 Feb; 54(2):167-72. PubMed ID: 23318292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
    Elshafeey N; Hassan I; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.
    Abrol S; Kotrotsou A; Salem A; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):43-53. PubMed ID: 28079714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR Imaging Pushes Radiologists to Move Forward in Oncologic Imaging.
    Luna A
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):xvii-xviii. PubMed ID: 26613887
    [No Abstract]   [Full Text] [Related]  

  • 20. Imaging in prostate cancer diagnosis: present role and future perspectives.
    Pinto F; Totaro A; Calarco A; Sacco E; Volpe A; Racioppi M; D'Addessi A; Gulino G; Bassi P
    Urol Int; 2011; 86(4):373-82. PubMed ID: 21372554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.